Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy helps diagnose and track alopecia areata by examining specific hair and scalp markers.

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Alopecia Areata causes significant structural and compositional changes in hair.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

Recognizing specific skin features helps diagnose and manage lupus erythematosus effectively.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Alopecia areata may be linked to heart issues.

Extracellular vesicles show promise for treating psoriasis by reducing inflammation and skin lesions.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

The study concluded that people with Lichen Planopilaris have a more diverse scalp bacteria and different metabolic pathways compared to healthy individuals.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.